KRISTYN MONTGOMERY: Open Payments
NPI 1780191304 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $195 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $43 |
| Tris Pharma Inc | 1 | $26 |
| Corium, LLC | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
Products named: REXULTI, SPRAVATO, AUSTEDO XR, Cologuard Collection Kit, Dyanavel XR, Azstarys, FANAPT, Xelstrym.
Industry payments across TX — which companies pay providers there.
